The hundred person wellness project and Google's baseline study: Medical revolution or unnecessary and potentially harmful over-testing?

BMC Medicine

Volumn 13, Issue 1, 2015, Pages

  Diamandis, Eleftherios P ^a,b,c  

^a MOUNT SINAI HOSPITAL   (Canada)

^b UNIVERSITY HEALTH NETWORK   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

Cancer screening; Incidental findings; Indolent disease; Over diagnosis; Over treatment; Population screening

Indexed keywords

ARTICLE; CANCER SCREENING; CANCER THERAPY; EARLY INTERVENTION; FLOW MEASUREMENT; HUMAN; HUNDRED PERSON WELLNESS PROJECT; INCIDENTAL FINDING; MASS SCREENING; MEDICAL RESEARCH; MICROBIOME; OUTCOME ASSESSMENT; PATIENT MONITORING; PUBLIC HEALTH; STUDY DESIGN; WELLBEING; FEMALE; HEALTH CARE DELIVERY; HEALTH PROMOTION; MALE; NEOPLASMS; PRIMARY PREVENTION; SEARCH ENGINE;

DELIVERY OF HEALTH CARE; FEMALE; HEALTH PROMOTION; HUMANS; MALE; MASS SCREENING; NEOPLASMS; PRIMARY PREVENTION; SEARCH ENGINE;

EID: 84924217281     PISSN: None     EISSN: 17417015     Source Type: Journal    
DOI: 10.1186/s12916-014-0239-6     Document Type: Article

References (19)

1. Institute for Systems Biology: 100K Wellness Project. [ http://research.systemsbiology.net/100k ]
2. Gibbs WW: Medicine gets up close and personal. Nature 2014, 506:144-145.
3. Kaiser J: Google X Sets Out To Define Healthy Human. ScienceInsider 2014. [ http://scim.ag/googlehuman ]
4. Hood L, Lovejoy JC, Price N: Integrating big data and actionable health coaching to optimize wellness. BMC Medicine 2015 doi:10.1186/s12916-014-0238-7.
5. Wilcken B: Newborn screening: gaps in the evidence. Science 2013, 342:197-198.
6. Chrystoja CC, Diamandis EP: Whole genome sequencing as a diagnostic test: challenges and opportunities. Clin Chem 2014, 60:1-10.
7. Annas GD, Sherman E: 23andMe and the FDA. N Engl J Med 2014, 370:985-988.
8. Roberts NJ, Vogelstein JT, Parmigiani G, Kinzler KW, Vogelstein B, Valculescu VE: The predictive capacity of personal genome sequencing. Sci Transl Med 2012, 4:133ra58.
9. Second Genome. [ http://www.secondgenome.com ]
10. Walsh CJ, Guinane CM, O'Toole PW, Cotter PD: Beneficial modulation of the gut microbiota. FEBS Lett 2014. S0014-5793(14)00254-3.
11. Schiffman M, Solomon D: Cervical-cancer screening with human papillomavirus and cytologic cotesting. N Engl J Med 2013, 369:2324-2331.
12. Levin TR, Corley DA: Colorectal cancer screening - coming of age. N Engl J Med 2013, 396:1164-1166.
13. Bleyer A, Welch HG: Effect of three decades of screening mammography on breast cancer incidence. N Engl J Med 2012, 367:1998-2005.
14. Biller-Andorno N, Juni P: Abolishing mammography screening programs. A view from the Swiss medical board. N Eng J Med 2014, 370:1965-1967.
15. Aberle DR, DeMello S, Berg CD, Black WC, Brewer B, Church TR, Clingan KL, Duan F, Fagerstrom RM, Gareen IF, Gatsonis CA, Gierada DS, Jain A, Jones GC, Mahon I, Marcus PM, Rathmell JM, Sicks J, National Lung Screening Trial Research Team: Results of the two incidence screenings in the national lunch screening trial. N Engl J Med 2013, 369:920-931.
16. Menon U, Gentry-Maharaj A, Hallett R, Ryan A, Burnell M, Sharma A, Lewis S, Davies S, Philpott S, Lopes A, Godfrey K, Oram D, Herod J, Williamson K, Seif MW, Scott I, Mould T, Woolas R, Murdoch J, Dobbs S, Amso NN, Leeson S, Cruickshank D, McGuire A, Campbell S, Fallowfield L, Singh N, Dawnay A, Skates SJ, Parmar M, Jacobs I: Sensitivity and specificity of multimodal and ultrasound screening for ovarian cancer, and stage distribution of detected cancers: results of the prevalence screen of the UK collaborative trial of ovarian cancer screening (UKCTOCS). Lancet Oncol 2009, 10:327-340.
17. Schröder FH, Hugosson J, Roobol MJ, Tammela TL, Ciatto S, Nelen V, Kwiatkowski M, Lujan M, Lilja H, Zappa M, Denis LJ, Recker F, Páez A, Määttänen L, Bangma CH, Aus G, Carlsson S, Villers A, Rebillard X, van der Kwast T, Kujala PM, Blijenberg BG, Stenman UH, Huber A, Taari K, Hakama M, Moss SM, de Koning HJ, Auvinen A, ERSPC Investigators: Prostate-cancer mortality at 11 years of follow-up. N Engl J Med 2012, 366:981-990. Erratum in: N Engl J Med 2012, 366:2137.
18. Hayes JH, Barry MJ: Screening for prostate cancer with the prostate-specific antigen test: a review of current evidence. JAMA 2014, 311:1143-1149.
19. Wilt TJ, Brawer MK, Jones KM, Barry MJ, Aronson WJ, Fox S, Gingrich JR, Wei JT, Gilhooly P, Grob BM, Nsouli I, Iyer P, Cartagena R, Snider G, Roehrborn C, Sharifi R, Blank W, Pandya P, Andriole GL, Culkin D, Wheeler T, Prostate Cancer Intervention versus Observation Trial (PIVOT) Study Group: Radical prostatectomy versus observation for localized prostate cancer. N Engl J Med 2012, 367:203-213.